According to the most recent financial data from July 2026, the EPS for the trailing twelve months is $2.94. Cooper Companies's EPS for 2025 amounted to $1.88, marking a drop from $1.97 in 2024. During the quarterly period ending on Jul 31, 2026, COO's EPS stood at $2.24.
Cooper Companies had an annual EPS of $1.88, indicating a drop of 4.6% from $1.97 in 2024. The quarterly per-share earnings for the period ending Jul 31, 2026, was $2.24, indicating a 357.1% increase from the same quarter last year. COO's 12-month EPS stands at $2.94 as of July 2026. Cooper Companies's annual EPS in 2024 stood at $1.97, a 32.2% increase year-over-year.
During the last 12 months, Cooper Companies has seen an EPS growth of 357.1% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -1.2% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 9.2%. A 10-year view shows that COO has seen an average EPS growth of 6% per year.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BSX Boston Scientific Corp | 17.26 | 55.6% | 63.3% | N/A |
| COO Cooper Companies Inc | 18.34 | -4.6% | -1.2% | 9.2% |
| NVS Novartis AG | 20.59 | 21.8% | 31.2% | 15.2% |
| UTMD Utah Medical Products Inc | 21.25 | -12.1% | -8.4% | 3.4% |
| JNJ Johnson & Johnson | 30.42 | 90.6% | 17.7% | 14.8% |
| TFX Teleflex Incorporated | N/A | -1,462.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.